CytoMed Therapeutics Financial Ratios for Analysis 2022-2024 | GDTC

Fifteen years of historical annual and quarterly financial ratios and margins for CytoMed Therapeutics (GDTC).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
14.080.60
0.040.45
0.047.20
--
--
--
--
--
--
--
--
--
--
-36.75-534.11
-36.79-551.81
-33.41-59.91
-35.46-294.91
0.740.05
-0.24-0.13
-0.25-0.18

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023-12-312023-06-302022-12-31
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
0.000.000.00
---